Journal Guides8 min readUpdated Mar 25, 2026

Diabetes Care Acceptance Rate

Diabetes Care does not publish a strong official acceptance rate. The better submission question is whether the study could change clinical diabetes management or ADA guideline recommendations.

Senior Researcher, Oncology & Cell Biology

Author context

Specializes in manuscript preparation and peer review strategy for oncology and cell biology, with deep experience evaluating submissions to Nature Medicine, JCO, Cancer Cell, and Cell-family journals.

Journal evaluation

Want the full journal picture?

See scope, selectivity, submission context, and what editors actually want before you decide whether the journal is realistic.

Open Journal GuideAnthropic Privacy Partner. Zero-retention manuscript processing.Run Free Readiness Scan

Quick answer: there is no strong official Diabetes Care acceptance-rate number you should treat as exact. The better submission question is whether the study could change how clinicians manage diabetes. With a 2025 JCR impact factor of ~16.6, Diabetes Care is the ADA's clinical practice journal — explicitly focused on care, not basic science. The editorial bar is about clinical impact, not just scientific rigor.

If the paper is a basic science study without a direct connection to diabetes management, the acceptance-rate discussion is mostly noise. The clinical relevance is the real issue.

What you can say honestly about the acceptance rate

The ADA does not publish a stable official acceptance rate for Diabetes Care. The journal's page describes scope and article types but omits acceptance-rate data.

Third-party aggregators report estimates that vary, and none have been confirmed by the ADA. The journal publishes monthly across five editorial categories — clinical care, epidemiology, technologies, pathophysiology, and health services — which is consistent with moderate-to-high selectivity.

What is stable is the editorial posture:

  • the journal is explicitly clinical: it covers care, education, nutrition, technology, and health services for diabetes
  • clinical trials, epidemiological studies, and technology evaluations are prioritized
  • the ADA Standards of Care (published annually in Diabetes Care) is the primary US clinical guideline for diabetes management
  • basic and translational research belongs in the companion journal Diabetes, not here

That clinical-first identity is the real filter. Papers whose primary advance is mechanistic rather than clinical are misaligned before any quality judgment is made.

What the journal is really screening for

At triage, the editor is usually asking:

  • does this study address how patients with diabetes are managed, monitored, or treated?
  • is the evidence clinical — trials, cohort studies, registry analyses, or technology evaluations?
  • does the work have potential to influence ADA Standards of Care or clinical guidelines?
  • is the patient population large enough and well-characterized enough for the conclusions drawn?

Papers that address the first question with clinical-level evidence will survive triage more reliably than studies with laboratory data or animal models.

The better decision question

For Diabetes Care, the useful question is:

Could this study influence how clinicians manage patients with diabetes, or how the ADA writes its Standards of Care?

If yes, the journal is a strong fit. If the paper is primarily mechanistic, primarily basic science, or primarily about a diabetes-adjacent metabolic condition, the acceptance rate is not the constraint. The clinical-care focus is.

Where authors usually get this wrong

The common misses are:

  • centering strategy around an unofficial percentage instead of checking clinical-care fit
  • submitting basic science or translational work that belongs in Diabetes instead
  • presenting small single-center clinical data without population-level implications
  • ignoring the journal's five editorial categories and sending a paper to the wrong section
  • underestimating the importance of the ADA Standards of Care alignment

Those are scope and significance problems before they are rate problems.

What to use instead of a guessed percentage

If you are deciding whether to submit, these pages are more useful than an unofficial rate:

Together, they tell you whether the paper has enough clinical relevance, whether the editorial requirements are manageable, and whether a different diabetes venue would be a cleaner first submission.

Practical verdict

The honest answer to "what is the Diabetes Care acceptance rate?" is that the ADA does not publish one, and third-party estimates should not be treated as precise.

The useful answer is:

  • yes, this is a selective clinical diabetes journal
  • no, a guessed percentage is not the right planning tool
  • use clinical-care impact, ADA guideline relevance, and patient-management significance as the real filter instead

If you want help pressure-testing whether this manuscript is positioned for a Diabetes Care submission before upload, a free Manusights scan is the best next step.

References

Sources

  1. 1. Diabetes Care, ADA, American Diabetes Association.
  2. 2. ADA Standards of Care in Diabetes, Diabetes Care annual supplement.
  3. 3. Clarivate Journal Citation Reports, 2025 edition (IF ~16.6).
  4. 4. SCImago Journal & Country Rank: Diabetes Care, Q1 ranking.

Reference library

Use the core publishing datasets alongside this guide

This article answers one part of the publishing decision. The reference library covers the recurring questions that usually come next: how selective journals are, how long review takes, and what the submission requirements look like across journals.

Open the reference library

Before you upload

Want the full journal picture?

Scope, selectivity, what editors want, common rejection reasons, and submission context, all in one place.

These pages attract evaluation intent more than upload-ready intent.

Anthropic Privacy Partner. Zero-retention manuscript processing.

Internal navigation

Where to go next

Open Journal Guide